The first patient I met as a medical student was a middle-aged delivery man and a former track athlete. He was recovering from his second amputation due to uncontrolled type 2 diabetes. When he told ...

Epstein's "great friend" returns to biotech, sex differences in suicide, and other health news from Morning Rounds ...

A new nonprofit called Radial is launching with at least $500 million to modernize the scientific process for the AI era.

Boris Nikolic’s career looked to be in tatters after his friendship with Jeffrey Epstein came to light in 2019. But he has quietly made a comeback, with some help from a top biotech VC.

AI agents to perform health care work are everywhere at HIMSS 2026. Experts want to know more about their validation.

Removing race from the eGFR had a big impact, resulting in 5.3 more kidney transplants per 1000 Black candidates.

Novo Nordisk received a warning from the Food and Drug Administration for failing to report suspected incidents of side effects caused by its medicines, a step that is required by federal law. In a ...

For physician Vishal Khetpal, the legal battle between Hims & Hers and Novo Nordisk (which, by the way, was settled yesterday) is just one symptom of something much larger going on with American ...

AI scribe company Nabla aims to be much more by using tech from Yann LeCun's new startup AMI, which just raised $1 billion.

Sen. Ron Johnson said he spoke to FDA Commissioner Marty Makary about the agency’s handling of rare disease treatments.

The exit of the FDA’s Vinay Prasad is being chalked up to a series of controversial decisions on rare disease drugs by the biologics center he directed. Read Lizzy Lawrence’s article on his upcoming ...

The FDA approves leucovorin for a rare brain disorder while retreating from top officials’ earlier insistence that it could benefit many children with autism.